LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

BeiGene Ltd ADR

Closed

SectorHealthcare

254.35 -0.88

Overview

Share price change

24h

Current

Min

249.82

Max

257.37

Key metrics

By Trading Economics

Income

153M

1.3M

Sales

-11M

1.1B

Profit margin

0.114

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+26.5% upside

Dividends

By Dow Jones

Next Earnings

6 Aug 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

255.23

Previous close

254.35

News Sentiment

By Acuity

50%

50%

167 / 380 Healthcare

BeiGene Ltd ADR Chart

Past performance is not a reliable indicator of future results.

Related News

12 May 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 Jan 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 Nov 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 Nov 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 Oct 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

7 May 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 May 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 May 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 May 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 May 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 May 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 Feb 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 Feb 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 Nov 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

7 Aug 2024, 10:05 UTC

Earnings

BeiGene 2Q Loss/Shr $1.15 >BGNE

7 Aug 2024, 10:04 UTC

Earnings

BeiGene 2Q Rev $929M >BGNE

Peer Comparison

Price change

BeiGene Ltd ADR Forecast

Price Target

By TipRanks

26.5% upside

12 Months Forecast

Average 326.72 USD  26.5%

High 359.47 USD

Low 259 USD

Based on 9 Wall Street analysts offering 12 month price targets forBeiGene Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

8

Buy

1

Hold

0

Sell

Sentiment

By Acuity

167 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeiGene Ltd ADR

BeiGene Ltd